Last updated: April 2026 Reviewed monthly as formularies and coverage policies change Disclaimer The information on this page is for educational and informational purposes only and is not intended as medical advice
People who need to be especially careful before and during use We explain cases where special caution is required during use, such as pre-existing conditions or medications currently being taken
Bu yaklam hem sindirimi hem de tokluk farkndaln olumlu etkileyebilir
seen in immunocompromised patients Diagnosis Biopsy definitive Dermoscopy helpful for melanocytic lesions Imaging if metastasis suspected Management Surgical excision mainstay (Mohs surgery for BCC/SCC on face) Radiotherapy selected cases Topical therapies for superficial lesions (5-FU, imiquimod) Systemic therapy / immunotherapy advanced melanoma (checkpoint inhibitors) BCC: most common, rarely metastasizes SCC: risk of metastasis, often sun-exposed areas Melanoma: aggressive, ABCDE features, high mortality if late Sun protection reduces risk for all types To view or add a comment, sign in A patient with melanoma faces more than a spot on the skin
In contrast, a microdose might start at just 0.05 mg to 0.25 mg weeklyoften less than one-tenth the full dose
